CalciMedica, Inc. (CALC) Total Return Calculator with Dividends Reinvested

CalciMedica, Inc.

Popular:

The total return for CalciMedica, Inc. (CALC) stock is -63.80% over the past 12 months. So far it's down 91.14% this year. The 5-year total return is -89.77%, meaning $10,000 invested in CALC stock 5 years ago would be worth $1,023 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in CALC 1 year ago, it would be worth $4,931 today — you'd have lost $5,069.

With Dividends Reinvested$4,931-50.69%

Price Only (No DRIP)$4,931-50.69%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in CALC

1Y$3,620-$6,380 (-63.8%)-63.8% CAGR

3Y$1,778-$8,222 (-82.2%)-43.8% CAGR

5Y$1,023-$8,977 (-89.8%)-36.6% CAGR

10Y$1,023-$8,977 (-89.8%)-20.4% CAGR

15Y$1,023-$8,977 (-89.8%)-14.1% CAGR

20Y$1,023-$8,977 (-89.8%)-10.8% CAGR

30Y$1,023-$8,977 (-89.8%)-7.3% CAGR

CalciMedica, Inc. did not pay dividends during this period. Total return = price return.

Loading CALC total return...

As of 2026-06-29

Performance Summary

Best Year+100.30%2025

Worst Year-51.03%2023

Max Drawdown-92.48%2026-01-02 → 2026-03-02

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-91.14%	—	-88.30%	—	$886
1Y	-63.80%	-63.80%	-44.83%	—	$3,620
3Y	-82.22%	-43.77%	-76.52%	—	$1,778
5Y	-89.77%	-36.62%	-86.49%	—	$1,023
10Y	-89.77%	-20.39%	-86.49%	—	$1,023
15Y	-89.77%	-14.10%	-86.49%	—	$1,023
20Y	-89.77%	-10.77%	-86.49%	—	$1,023
30Y	-89.77%	-7.32%	-86.49%	—	$1,023

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-92.34%	-92.34%	—	+0.41%	-92.8pp
2025	+100.30%	+100.30%	—	+16.64%	+83.7pp
2024	+15.50%	+15.50%	—	+24.00%	-8.5pp
2023	-51.03%	-51.03%	—	+24.81%	-75.8pp

CALC underperformed the S&P 500 by 84.64pp over the past year (-63.80% vs +20.84%).

Loading summary...

CALC Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
CALCCalciMedica, Inc.	$12M	+3.8%	-91.1%	-63.8%	—	-82.2%	-89.8%	-89.8%
ACRSAclaris Therapeutics, Inc.	$603M	+10.9%	+66.3%	+215.1%	—	-51.1%	-72.0%	-73.5%
IMVTImmunovant, Inc.	$8.0B	+14.8%	+47.5%	+138.9%	—	+98.5%	+247.5%	+284.1%
PRAXPraxis Precision Medicines, Inc.	$9.5B	-6.5%	+7.9%	+602.8%	—	+1824.9%	+5.4%	-25.9%
INVAInnoviva, Inc.	$1.7B	+3.9%	+19.0%	+14.3%	—	+87.0%	+75.6%	+129.1%
ARDXArdelyx, Inc.	$1.4B	-11.2%	+0.7%	+68.2%	—	+82.6%	+214.2%	+208.0%
XNCRXencor, Inc.	$1.1B	+29.4%	-3.2%	+74.7%	—	-41.7%	-59.9%	+7.8%
KYMRKymera Therapeutics, Inc.	$8.8B	+33.9%	+37.3%	+111.9%	—	+342.1%	+125.5%	+200.3%
CRVSCorvus Pharmaceuticals, Inc.	$1.1B	+5.1%	+76.9%	+198.4%	—	+528.6%	+360.9%	-2.6%
BMYBristol-Myers Squibb Company	$117.4B	-0.9%	+5.2%	+22.3%	+5.3pp	-3.9%	+1.1%	+6.1%
ABBVAbbVie Inc.	$444.4B	+18.0%	+3.9%	+30.2%	+3.6pp	+88.3%	+131.2%	+374.7%

Compare:CALC vs ACRS CALC vs IMVT CALC vs PRAX CALC vs ACRS vs IMVT

About CALC Dividend Returns

CalciMedica, Inc. (CALC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CALC over the past year?

CalciMedica, Inc. (CALC) delivered a return of -63.80% over the past year. Since CALC does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in CALC be worth today?

A $10,000 investment in CalciMedica, Inc. one year ago would be worth $3,620 today, representing a loss of $6,380.

Q3Does CALC pay dividends?

CalciMedica, Inc. (CALC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CALC, the total return equals the price-only return.

Q4Did CALC beat the S&P 500?

No, CalciMedica, Inc. (CALC) underperformed the S&P 500 by 84.64 percentage points over the past year. CALC delivered a total return of -63.80%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed CALC by 84.64pp during this period.

Q5What is CALC's worst drawdown?

CalciMedica, Inc. (CALC) experienced a maximum drawdown of -92.48% over the past year, declining from its peak on 2026-01-02 to its trough on 2026-03-02. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CALC's long-term total return over 10, 20, or 30 years?

Here are CalciMedica, Inc. (CALC)'s long-term returns with dividends reinvested. Over 10 years, the total return is -89.8% (-20.4% CAGR) — $10,000 would have grown to $1,023. Over 20 years: -89.8% total return (-10.8% CAGR) — $10,000 → $1,023. Over 30 years: -89.8% total return (-7.3% CAGR) — $10,000 → $1,023. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CALC's best and worst year?

CalciMedica, Inc.'s best calendar year was 2025 with a total return of 100.3%. Its worst year was 2023 with a total return of -51.0%. This range shows the volatility investors should expect — the difference between the best and worst year is 151.3 percentage points.

How much would $100/month in CALC be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →